MedTrace Logo

Alteplase in Elderly Acute Ischemic Stroke (AIS) Patients During Hospitalization

NCT05395351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113035

Last updated 2024-12-20

Study results available
· View outcomes & findings →

Summary

The objective of the study is to find out the in-hospital clinical outcomes among Chinese Acute Ischaemic Stroke (AIS) patients, who were treated with intravenous (IV) Recombinant Tissue Plasminogen Activator (rt-PA) within 4.5 hours of symptom onset in different age groups (18 to 80 years and above 80 years).

Conditions

Interventions

DRUG

rt-PA

Intravenous recombinant tissue plasminogen activator (IV rt-PA)

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-11-30
Primary Completion
2023-03-28
Completion
2023-03-28

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05395351 on ClinicalTrials.gov